An open-label, randomized, multicenter trial to evaluate continuation rates, side effects and acceptability of NuvaRing [ethinyl estradiol/etonogestrel] versus OrthoEvra [ethinyl estradiol/norelgestromin]

Trial Profile

An open-label, randomized, multicenter trial to evaluate continuation rates, side effects and acceptability of NuvaRing [ethinyl estradiol/etonogestrel] versus OrthoEvra [ethinyl estradiol/norelgestromin]

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2018

At a glance

  • Drugs Ethinylestradiol/etonogestrel (Primary) ; Ethinylestradiol/norelgestromin (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Acronyms PARIS
  • Most Recent Events

    • 24 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top